Over the last seven years, the ӳý of MIT and Harvard has helped systematically uncover, catalog, and analyze the microbial inhabitants of the human microbiome. Research is now focused on using “multi-omics” techniques, including whole genome sequencing, as well as proteomic, metabolomic, and transcriptomic analyses, to better understand how the microbiota is acting on and interacting with its human hosts in health, and during disease progression.
Scientists at the ӳý share ideas and launch collaborative projects to tackle key challenges. The IDM program includes collaborations across several ӳý programs and platforms as well as many other labs in the Harvard/MIT community and beyond.